• 25th October 2017

Please click here to see the article

Anna Middleton on behalf of the AGNC and BSGM contributed to this position statement from the ASHG on genome editing which is very topical given recent media attention to the use of this technology in the context of embryos with variants predisposing to hypertrophic cardiomyopathy